Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
72.8 CAD | +0.03% | +1.85% | +25.17% |
04-15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
04-12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.42% | 306B | |
+11.86% | 153B | |
+52.00% | 124B | |
+22.62% | 83.43B | |
+12.30% | 78.06B | |
+21.28% | 62.81B | |
+14.16% | 60.08B | |
+13.06% | 49.91B | |
+32.60% | 37.05B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Ovintiv Brief: Co Accelerated its $4.5 Billion Total Debt Target Timeline to First Half of 2022 and Forecasts Its YE 2021 total debt to be less than $5 billion, assuming $50 WTI oil and $2.75 NYMEX natural gas prices